Literature DB >> 9741121

Serotype H5a5b is a major clone within mosquito-pathogenic strains of Bacillus sphaericus.

V Zahner1, H Momen, F G Priest.   

Abstract

Seventy six mosquito pathogenic strains of Bacillus sphaericus and 10 non-pathogens were examined by pulsed field gel electrophoresis (PFGE) of SmaI-digested chromosomal DNA. Non-pathogenic strains were clearly distinguished from the entomopathogenic types which were assigned to 21 groups (SmaI restriction patterns; SRPs). Some agreement between SRP based on PFGE and serotyping was noted, in particular all 39 strains of serotype 5a5b examined revealed identical SRPs indicating total conservation of the SmaI restriction site in these bacteria. Serotype 5a5b (SRP 12) strains comprise a widely distributed and abundant clonal lineage. Most serotypes, however, were divided into several SRPs. Seven strains from serotype 2a2b were covered in five SRPs in which toxin synthesis was correlated with chromosomal structure. Similarly, toxicity correlated with SRP in strains from serotypes 3 and 6.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741121     DOI: 10.1016/S0723-2020(98)80020-9

Source DB:  PubMed          Journal:  Syst Appl Microbiol        ISSN: 0723-2020            Impact factor:   4.022


  3 in total

1.  Genotypic diversity among Brevibacillus laterosporus strains.

Authors:  V Zahner; L Rabinovitch; P Suffys; H Momen
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

2.  Extended genetic analysis of Brazilian isolates of Bacillus cereus and Bacillus thuringiensis.

Authors:  Viviane Zahner; Ana Carolina Telles de Carvalho e Silva; Gabriela Pinhel de Moraes; Douglas McIntosh; Ivano de Filippis
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-02       Impact factor: 2.743

3.  Dynamics of Bacillus thuringiensis var. israelensis and Lysinibacillus sphaericus spores in urban catch basins after simultaneous application against mosquito larvae.

Authors:  Valeria Guidi; Angelika Lehner; Peter Lüthy; Mauro Tonolla
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.